Clariant AG (OTCMKTS:CLZNY – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the nine analysts that are covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, two have assigned a buy rating and two have issued a strong buy rating on the company.
Several equities research analysts have issued reports on the stock. Jefferies Financial Group upgraded shares of Clariant from a “moderate sell” rating to a “hold” rating in a research report on Thursday, August 6th. Barclays upgraded Clariant to an “overweight” rating in a research note on Monday, August 3rd. Morgan Stanley cut shares of Clariant from an “overweight” rating to an “underweight” rating in a research report on Monday, July 20th. The Goldman Sachs Group upgraded shares of Clariant to a “strong-buy” rating in a research note on Thursday, August 20th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Clariant from a “hold” rating to a “buy” rating in a research report on Monday, August 3rd.
Read Our Latest Stock Report on Clariant
Clariant Price Performance
Clariant Company Profile
Clariant AG is a Switzerland-based specialty chemicals company that traces its roots back to a spin-off from Sandoz in 1995. Headquartered in Muttenz near Basel, the firm develops, manufactures and markets a broad portfolio of chemical solutions for industries worldwide. While its primary listing is on the SIX Swiss Exchange, Clariant’s shares also trade OTC under the symbol CLZNY, reflecting its global investor reach.
The company operates through three core segments: Care Chemicals, Catalysis and Natural Resources.
Further Reading
- Five stocks we like better than Clariant
- Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?
- Optical Cable Corporation Is Starting to Get the Market’s Attention
- Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers
- Is Nike’s Index Demotion a Warning or a Buying Opportunity?
Receive News & Ratings for Clariant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clariant and related companies with MarketBeat.com's FREE daily email newsletter.
